Premium
Extracorporeal Life Support as Ultimate Strategy for Refractory Severe Cardiogenic Shock Induced by Tako‐tsubo Cardiomyopathy: A New Effective Therapeutic Option
Author(s) -
Bonacchi Massimo,
Valente Serafina,
Harmelin Guy,
Gensini Gian Franco,
Sani Guido
Publication year - 2009
Publication title -
artificial organs
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.684
H-Index - 76
eISSN - 1525-1594
pISSN - 0160-564X
DOI - 10.1111/j.1525-1594.2009.00825.x
Subject(s) - cardiogenic shock , medicine , refractory (planetary science) , extracorporeal , cardiology , cardiomyopathy , shock (circulatory) , extracorporeal circulation , acute coronary syndrome , coronary artery disease , myocardial infarction , heart failure , physics , astrobiology
We report a possible new therapeutic strategy, using extracorporeal cardiopulmonary support (ECLS), for severe refractory cardiogenic shock (SRCS) in a patient with Tako‐tsubo cardiomyopathy (TC). TC is a syndrome characterized by left ventricular wall motion abnormalities, without coronary artery disease, mimicking the diagnosis of acute coronary syndrome. This ventricular dysfunction can be reversible; however, it can progress into refractory cardiogenic shock with limited therapeutic options available. For the first time in a Tako‐tsubo patient with refractory cardiogenic shock, we used ECLS treatment in order to rest the heart, sustain circulation and end‐organ perfusion, and promote potential ventricular recovery. ECLS might be the selected treatment for SRCS in patients with TC, and seems to be an effective and useful ultimate therapeutic strategy for preventing death.